NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2)
Details
- Buyer
- NHS England
- Supplier(s)
63 suppliers
- Accord UK Ltd
- AOP Orphan Ltd
- Arcadia Pharma Limited T/A Arcadia Medical
- Ascend Laboratories (UK) Limited
- Aspen Pharmacare UK Limited
- Baxter Healthcare Ltd
- Bayer Public Limited Company
- Beaumont Pharma Ltd
- Bristol Laboratories Ltd
- Brown and Burk
- Chiesi Ltd
- Cipla
- Clydesdale Pharma ltd
- Correvio GmbH
- Crescent Pharma Limited
- Derma UK
- Dr Falk Pharma UK Ltd
- DRUGSRUS LIMITED
- Eramol (UK) Ltd
- Evolan Pharma
- Ferring Pharmaceutical
- Focus Pharmaceuticals Ltd
- Galen Ltd
- Galvany Pharma Ltd
- Genesis Pharmaceuticals Ltd
- JCSH Pharma Ltd
- Krka UK ltd
- Kyowa Kirin Ltd
- LogixX Pharma Ltd
- Lundbeck Limited
- Lupin Healthcare (UK) Ltd
- Macure Pharma ApS
- Manx Healthcare Ltd
- Medley Pharma Ltd
- MSN Laboratories Europe Limited
- Necessity Supplies Ltd
- Neon Healthcare Ltd
- Norgine Pharmaceuticals Limited
- Oralieve UK Ltd
- Orion Pharma (UK) Ltd
- P M Pharma
- Phoenix Lab
- Reckitt Benckiser
- Recordati Pharmaceuticals Ltd
- Reig Jofre UK Ltd
- RELONCHEM LIMITED
- Rivopharm
- RPH Pharmaceuticals AB
- Scope Ophthalmics Ltd
- Stirling Anglian Pharmaceuticals Ltd
- Strandhaven Limited t/a Berg Pharmacy
- Strides Pharma Uk LTD
- Synchrony
- Syri Limited (T/A Thame Laboratories)
- Takeda UK Limited
- Tetris Pharma Lts
- Thea Pharmaceuticals Ltd
- Tillomed Laboratories Ltd
- Torrent Pharma (UK) Ltd
- Typharm Ltd
- Uni Health Distribution Ltd
- Vantage Pharmaceuticals Ltd
- Waymade plc
- Value
- GBP 1
- Duration
- 3 years
- Topic
- Pharmaceutical products
- Published
- 14 May 2024
- Source
- uk:contracts_finder
Tender description
Invitation to offer for NHS National Generic Pharmaceuticals - Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)
Timeline
- Completed: Award published14 May 2024Current notice
- Completed: Award date1 June 2024
- Next: Contract expiry date31 May 2027in 9 months
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
6 similar open tenders
See more open tenders related to NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2).
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related topics
Topics related to NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2), ranked by notice volume.
- 16,740£389.4bn
- 92,792£10.4tn
Related buyers
Buyers similar to NHS England.
- 464£2.1bn
- 376£250.5m
- 367£15.0bn
- 304£2.8bn
- 271£904.1m
- 268£20.1bn
- 255£517.2m
- 203£1.0bn
- 147£900.8m
- 135£63.9m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
